Post-COVID sequels in patients attended at the Dr. Manuel Ferrer Valdés polyclinic, Panama.
Article Sidebar
Main Article Content
Abstract
Introduction: following the COVID-19 pandemic, many patients have persisted with prolonged COVID and there are few studies that characterize the epidemiology, symptoms, and its impact on work
Objective: to describe the post-COVID sequelae in patients treated in the post-COVID clinic.
Methods: observational, cross-sectional study with information from the records of patients with post-COVID sequelae from the Dr. Manuel Ferrer Valdés Polyclinic, 2021-2022, to determine demographic data, prevalence of comorbidities, vaccine doses, post-COVID sequelae, time of disability, and return to work. A sample of 321 patients was obtained.
Results: 61.7 % were female, between 45-64 years old (55 %). 90% were workers and 10 % pensioners and beneficiaries. According to economic activity, 72 % work in the service sector, followed by commerce (6.5 %), transport, warehouse and communications (4.4 %). Nearly 85 % of patients reported at least one comorbidity, led by high blood pressure (45.8 %), obesity (30.8 %) and dyslipidemia (24 %). The majority (68.5 %) had mild cases, whose main symptoms were fatigue (68.2 %), dyspnea (50.8 %), and cough (37.7 %). Almost half (46.7 %) had 15 days of disability and 77 % returned to work, of which 80 % reported work limitations.
Conclusion: post-COVID sequelae generate a significant global burden of disease with a negative impact on work. The findings of the study are intended for the planning and distribution of resources for the prevention, management and rehabilitation of these patients
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
1. Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021;52:575-81.
2. Boix V, Merino E. Post-COVID syndrome. The never-ending challenge. Síndrome post-COVID. El desafío continúa. Med Clin (Barc). 2022;158:178-80.
3. Papineau A, Bibi L. Manifestaciones clínicas de post COVID en adultos en la República de Panamá. 2022.
4. Bonifácio LP, Csizmar V, Barbosa-Júnior F, Pereira A, KoenigkamSantos M, Wada DT, et al. Long-term symptoms among COVID-19 survivors in prospective cohort study, Brazil. Emerg Infect Dis. 2022;28:730-3.
5. Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (postacute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. 2021;18:2621.
6. Centers for Disease Control and Prevention. Long COVID or postCOVID conditions. 2021 Sep 16. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
7. Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15:869-75.
8. Docherty AB, Harrison EM. Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.
9. Organización Mundial de la Salud. Manejo clínico de la COVID-19: orientaciones evolutivas. WHO/2019-nCoV/clinical/2021.2. 2021.
10. Tenforde MW. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March– June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993-8.
11. Arnold DT, Hamilton FW. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020;76:399-401.
12. Nabavi N. Long COVID: how to define it and how to manage it. BMJ. 2020;370:m3489.
13. Sudre CH, Murray B, Steves CJ. Attributes and predictors of longCOVID: analysis of COVID cases and their symptoms collected by the COVID Symptom Study App. medRxiv. 2020.
14. Colafrancesco S, Alessandri C, Conti F, Priori R. COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? Autoimmun Rev. 2020;19:102573.
15. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363-74.
16. Wu F, Wang A, Xia S. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv. 2020.
17. Gemelli. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020;32:1613-20.
18. Forte G, Favieri F, Tambelli R, Casagrande M. COVID-19 pandemic in the Italian population: validation of a post-traumatic stress disorder questionnaire and prevalence of PTSD symptomatology. Int J Environ Res Public Health. 2020;17:4151.
19. Zhang Y, Li R. Social media exposure, psychological distress, emotion regulation, and depression during the COVID-19 outbreak in community samples in China. Front Psychiatry. 2021;12:644899.
20. Greenhalgh T, Knight M, A’Court C. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026.